A simple urine test could accurately detect recurring kidney cancer in patients recovering from surgery for the disease, potentially sparing them from frequent follow-up scans, researchers suggest.The ...

Sid Sadler discusses kidney cancer awareness, patient advocacy and the need for specialized care to improve access to ...

A new urine-based biomarker test could cut in half the need for surveillance imaging to detect recurrence of the most common ...

We need to keep supporting this kind of research,” a Connecticut researcher and doctor said. “To see if we replicate these ...

The AUR87A study found that urine collected biomarkers could accurately predict recurrence of kidney cancer in post-surgery ...

The company presented its results this week at a conference and anticipates that with additional validation early next year it will be ready to file for regulatory approval.

Excess weight in midlife is a known risk factor for kidney cancer, but new research indicates that weight patterns throughout ...

A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has shown ...

Among patients with renal cell carcinoma, those with larger tumors may yield the most benefit from SBRT compared with other ...

Elypta AB’s urine-based test correctly identified 90% of patients whose kidney cancer had returned, according to results from an ongoing study. The company’s metabolism-based liquid biopsy platform, ...

Swedish cancer diagnostic company Elypta’s urine test has been able to accurately identify 90% of patients with recurrent kidney cancer. The business announced the intermediary results from its ...